Division of Allergy, Immunology, and Infectious Diseases

Our specialists in infectious diseases provide a full range of consultative services for adults with infections. These conditions include but are not limited to, post-surgical infections, infections in transplant and other immunocompromised patients, and infections of the skin, bones, joints, lungs, and intestines. In addition, we manage and treat patients with HIV infection and/or chronic hepatitis B and C.

The division’s allergy and immunology specialist evaluates and treats adults and children with allergic and immunologic disorders. Services include testing for allergies to medications and environmental triggers, desensitization (“allergy shots”), and management of immune deficiencies.

View Our Faculty Listing Clinical Programs

The Division's faculty has a broad range of research interests. These include hospital epidemiology, diagnostic testing, development and evaluation of innovative culture and nonculture-based systems to detect bloodstream infections; laboratory detection of emerging antimicrobial resistance; improved methods of in vitro susceptibility testing; implementation of systems to optimize the rational use of antimicrobial agents; and clinical trials of innovative antibiotics for multidrug-resistant bacteria. 
In addition, the ID and allergy faculty annually mentor medical students, medical residents and ID fellows in numerous quality assurance and other clinical research projects. 

Albin, O. R., Troost, J. P., Saravolatz, L., 2nd, Thomas, M. P., Hyzy, R. C., Konkle, M. A., Weirauch, A. J., Dickson, R. P., Rao, K., & Kaye, K. S. (2024). A quasi-experimental study of a bundled diagnostic stewardship intervention for ventilator-associated pneumonia. Clin Microbiol Infect, 30(4), 499-506. https://doi.org/10.1016/j.cmi.2023.12.023

Bhowmick, T., Abdul Azim, A., Narayanan, N., & Kaye, K. (2023). Traits and skills of effective leaders in antimicrobial stewardship. Antimicrob Steward Healthc Epidemiol, 3(1), e222. https://doi.org/10.1017/ash.2023.499

Dhar, S., Jinadatha, C., Kilgore, P. E., Henig, O., Divine, G. W., Todter, E. N., Coppin, J. D., Carter, M. J., Chopra, T., Egbert, S., Carling, P. C., & Kaye, K. S. (2024). Lowering the Acquisition of Multi-drug Resistant Organism (MDROs) with Pulsed-xenon (LAMP) Study: a cluster randomized controlled, double-blinded, interventional crossover trial. Clin Infect Dis. https://doi.org/10.1093/cid/ciae240

Kaye, K. S., McLeod, S. M., O'Donnell, J. P., & Altarac, D. (2023). Sulbactam-durlobactam for infections caused by Acinetobacter baumannii-calcoaceticus complex - Authors' reply. Lancet Infect Dis, 23(8), e275-e276. https://doi.org/10.1016/S1473-3099(23)00423-1

Kerai, A., Doshi, S., Laleker, A., & Majumdar, A. (2024). Fungal Foe and Mechanical Hearts: A Retrospective Case Series on Candida auris Bloodstream Infection With Left Ventricular Assist Devices. Open Forum Infect Dis, 11(6), ofae286. https://doi.org/10.1093/ofid/ofae286

Majumdar, A., Shah, M. R., Park, J. J., Narayanan, N., Kaye, K. S., & Bhatt, P. J. (2023). Challenges and Opportunities in Antimicrobial Stewardship among Hematopoietic Stem Cell Transplant and Oncology Patients. Antibiotics (Basel), 12(3). https://doi.org/10.3390/antibiotics12030592

McDonald, E. G., Aggrey, G., Tarik Aslan, A., Casias, M., Cortes-Penfield, N., Dong, M. Q. D., Egbert, S., Footer, B., Isler, B., King, M., Maximos, M., Wuerz, T. C., Azim, A. A., Alza-Arcila, J., Bai, A. D., Blyth, M., Boyles, T., Caceres, J., Clark, D., . . . Lee, T. C. (2023). Guidelines for Diagnosis and Management of Infective Endocarditis in Adults: A WikiGuidelines Group Consensus Statement. JAMA Netw Open, 6(7), e2326366. https://doi.org/10.1001/jamanetworkopen.2023.26366

McLeod, S. M., O'Donnell, J. P., Narayanan, N., Mills, J. P., & Kaye, K. S. (2024). Sulbactam-durlobactam: a beta-lactam/beta-lactamase inhibitor combination targeting Acinetobacter baumannii. Future Microbiol, 19(7), 563-576. https://doi.org/10.2217/fmb-2023-0248

Mohayya, S. M., Arsalan, M., Narayanan, N., Patel, P., Hong, C. G., Kirn, T. J., Bhatt, P. J., & Bhowmick, T. (2023). Impact of phenotypic rapid diagnostic assay on duration of empiric antibiotics for gram-negative bacteremia. Antimicrob Steward Healthc Epidemiol, 3(1), e22. https://doi.org/10.1017/ash.2022.331

Patell, R., Cool, J. A., Merchant, E., Dodge, L. E., Ricotta, D. N., Persaud, B., Gomez, L. K., Yang, L., Trainor, A., Carney, B., William, J., Lecker, S., Theodore, M., Petri, C., Horst, D., Stein, D., Forbath, N., Azim, A., Hale, A. J., & Freed, J. A. (2024). Rethinking the consultation paradigm: Validity evidence for a new framework, a multimethods study. J Hosp Med, 19(4), 259-266. https://doi.org/10.1002/jhm.13312

Pierce, V. M., Bhowmick, T., & Simner, P. J. (2023). Guiding antimicrobial stewardship through thoughtful antimicrobial susceptibility testing and reporting strategies: an updated approach in 2023. J Clin Microbiol, 61(11), e0007422. https://doi.org/10.1128/jcm.00074-22

Rao, K., Zhao, Q., Bell, J., Krishnan, J., Henig, O., Daniel, J., Sawaya, K., Albin, O., Mills, J. P., Petty, L. A., Gregg, K., Kaul, D., Malani, A. N., Pogue, J., & Kaye, K. S. (2024). An Open-Label, Randomized Trial Comparing Fidaxomicin With Oral Vancomycin for the Treatment of Clostridioides difficile Infection in Hospitalized Patients Receiving Concomitant Antibiotics for Concurrent Infections. Clin Infect Dis, 78(2), 277-282. https://doi.org/10.1093/cid/ciad606

Roy, A. S., Hagh-Doust, H., Abdul Azim, A., Caceres, J., Denholm, J. T., Dong, M. Q. D., King, M., Yen, C. F., Lee, T. C., & McDonald, E. G. (2023). Multidisciplinary Teams for the Management of Infective Endocarditis: A Systematic Review and Meta-analysis. Open Forum Infect Dis, 10(9), ofad444. https://doi.org/10.1093/ofid/ofad444

Simon Frances, B., Nair, N., Gaur, A., Plotz, B., & Majumdar, A. (2023). Spectre of COVID-19 infection confounding myocarditis related to cytomegalovirus mononucleosis syndrome and hyperinflammatory syndrome. Heliyon, 9(11), e21383. https://doi.org/10.1016/j.heliyon.2023.e21383

Sui, J., Lin, Z., Azizpour, S., Chen, F., Gaur, S., Keene, K., Soleimani, F., Bhowmick, T., Rafique, Z., & Javanmard, M. (2024). Clinical evaluation of a fully electronic microfluidic white blood cell analyzer. PLoS One, 19(1), e0296344. https://doi.org/10.1371/journal.pone.0296344

Yang, A. F., Sherman, A., Nazarian, E., Haas, W., Mehr, J., Pedrani, M., Kirn, T., Brant, S., Boruchoff, S. E., Kaye, K. S., & Mills, J. P. (2024). Evidence of transmission of New Delhi metallo-beta-lactamase-producing Klebsiella pneumoniae through a gastrointestinal endoscope without an elevator channel. Infect Control Hosp Epidemiol, 1-6. https://doi.org/10.1017/ice.2024.55

Yassin, A., Kaye, K. S., & Bhowmick, T. (2024). Unitary Tract Infection Treatment: When to Use What Agents including Beta-lactam Combination Agents. Infect Dis Clin North Am, 38(2), 295-310. https://doi.org/10.1016/j.idc.2024.03.007

Being immunocompromised (or having a weakened immune system) from cancer or a transplant can put you at risk for certain infections. If you are anticipating a transplant or recently received one, you want to make sure that you are receiving appropriate evaluation to prevent these infections.

The Robert Wood Johnson Medical School (RWJMS) and Robert Wood Johnson University Hospital Transplant Infectious Disease program’s mission is to provide comprehensive care for the evaluation and management of infections related to hematologic malignancies, bone marrow transplantation, chimeric antigen receptor T-cell (CAR-T) therapy, left ventricular assist device and solid organ transplantation.

If you are anticipating a transplant or recently received one, you want to make sure that you are receiving appropriate evaluation to prevent any infections.

Our experienced clinicians, part of the Division of Allergy, Immunology, and Infectious Disease, are trained to treat transplant and immunocompromised patients with a multidisciplinary approach. Our program works closely with, RWJUH New Brunswick Kidney and Pancreas Transplant Center, Advanced Heart Failure, VAD, and Transplant program, and the Rutgers Cancer Institute of New Jersey to ensure the best possible outcomes.

• Pre-transplant evaluation and management
• Patient education and counseling for pre-and post-transplant recipients
• Post-transplant infectious disease management
  • Bone marrow transplant
  • Heart transplant
  • Kidney transplant
  • Pancreas transplant
• Left Ventricular Assist Device (LVAD) infection management
• Hematologic and solid tumor-related infection management
• Transplant ID

To make an appointment with our transplant infectious disease physicians, call 732-235-7060.